ornithine has been researched along with Amyloid Neuropathy Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barroso, E; Coelho, AV; Cordeiro, C; da Costa, G; Freire, AP; Gomes, RA; Guerreiro, A; Mateus, É; Monteiro, E | 1 |
| Barroso, E; Cordeiro, C; Freire, A; Gomes, R; Martins, A; Monteiro, E; Pereira, P; Ponces Freire, A; Quintas, A; Sousa Silva, M | 1 |
2 other study(ies) available for ornithine and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.
Topics: Adult; Amyloid Neuropathies, Familial; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Female; Fibrinogen; Glycosylation; Humans; Liver Transplantation; Male; Middle Aged; Models, Molecular; Molecular Chaperones; Ornithine; Prealbumin; Protein Binding; Protein Stability; Protein Structure, Quaternary; Pyrimidines; Temperature; Time Factors; Young Adult | 2011 |
Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy.
Topics: Adipose Tissue; Adult; Amyloid; Amyloid Neuropathies, Familial; Female; Glycation End Products, Advanced; Humans; Maillard Reaction; Male; Ornithine; Pyrimidines; Pyruvaldehyde | 2005 |